Rating History for Biohaven Pharma (BHVN) by BofA Securities
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/29/2026 | Jason Gerberry | Downgrade | Underperform (Neutral) |
11.00 (12.00) |
15.83 (15.44) |
-2.46% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||


